Glazer Capital’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
Glazer Capital's OACC Position: Q2 2026 in Review
Glazer Capital reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 0.08% in Q2 2026, selling an estimated $2.91K and leaving 357,649 shares worth $3.83M. The position accounts for 0.09% of the portfolio, ranked #200.
Glazer Capital first reported a position in OACC in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.96M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q2 2026.
- Glazer Capital held 357,649 shares of Oaktree Acquisition Corp III Life Sciences worth $3.83M as of Q2 2026.
- Glazer Capital sold 273 Oaktree Acquisition Corp III Life Sciences shares in Q2 2026, an estimated $2.91K.
- Oaktree Acquisition Corp III Life Sciences made up 0.09% of Glazer Capital's portfolio in Q2 2026, its #200 holding.
- Glazer Capital first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and has held it in 6 quarters since.
- Glazer Capital's Oaktree Acquisition Corp III Life Sciences position peaked at $3.96M in Q1 2025.
- 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2026.
Based on Glazer Capital's 13F filing for Q2 2026, filed 17 Aug 2026.